[DAIKEN BIOMEDICAL*] Revises "Share Repurchase and Transfer to Employees Regulations" as Instructed by Regulatory Authority
NQ Score
0/100
N1 Content Completeness
0
AI Summary (NQ-processed)
Daiken Biomedical International Co., Ltd. is revising its "Share Repurchase and Transfer to Employees Regulations" to comply with regulatory instructions. The changes update the definition of eligible employees and refine the process for determining subscription qualifications and quantities for share repurchases.